Finafloxacin

Overview

Finafloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1908370).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Finafloxacin expires 21 Nov 2033. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid

Canonical SMILES

C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4C[C@H]5[C@H](C4)OCCN5)F)C(=O)O

InChIKey

FYMHQCNFKNMJAV-HOTGVXAUSA-N